Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan

Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan

Takashi Shigematsu,1 Ryutaro Shimazaki,2 Masafumi Fukagawa,3 Tadao Akizawa4 On behalf of the Evocalcet Study Group 1Department of Nephrology, Wakayama Medical University, Wakayama, Japan; 2R&D Division, Kyowa Hakko Kirin Co., Ltd., Chiyoda-ku, Tokyo, Japan; 3Department of Internal Medicine,...

Full description

Bibliographic Details
Main Authors: Shigematsu T, Shimazaki R, Fukagawa M, Akizawa T
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Clinical Pharmacology : Advances and Applications
Subjects:
Calcimimetics
evocalcet
hemodialysis
parathyroid hormone
secondary hyperparathyroidism
Online Access:https://www.dovepress.com/pharmacokinetics-of-evocalcet-in-secondary-hyperparathyroidism-patient-peer-reviewed-article-CPAA

Internet

https://www.dovepress.com/pharmacokinetics-of-evocalcet-in-secondary-hyperparathyroidism-patient-peer-reviewed-article-CPAA

Similar Items